A Look At The Fair Value Of IBEX Technologies Inc. (CVE:IBT)
May 22
Canadian (TSX) Biotech Industry Analysis
Updated-
DataAggregated Company Financials
Companies0
- 7Dn/a
- 3Mn/a
- 1Yn/a
- YTDn/a
Over the last 7 days, the Biotech industry has dropped 2.1%, driven by Oncolytics Biotech declining 23%. In contrast, Reunion Neuroscience has gained 59%. This takes the industry's 12 month performance to a gain of 28%. Looking forward, earnings are forecast to grow by 48% annually.
Industry Valuation and Performance
Has the Canadian Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|
Loading
Current Industry PE
- Investors are optimistic on the Canadian Biotechnology industry, and appear confident in long term growth rates.
- The industry's 3-year average PS ratio of 32.3x is exceeded by the industry's current PS ratio of 45.0x.
Past Earnings Growth
- The earnings for companies in the Biotechnology industry have deteriorated over the last three years.
- Revenues have also declined 19% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does Canadian Biotech compare with similar industries?
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| REUN Reunion Neuroscience | CA$1.51 | 58.9% +CA$6.6m | -73.3% | PS3.6x | |
| MSCL Satellos Bioscience | CA$0.60 | 9.1% +CA$5.6m | -18.9% | PB31.8x | |
| MDNA Medicenna Therapeutics | CA$0.79 | 9.7% +CA$4.9m | -33.1% | PB1.7x | |
| IBT IBEX Technologies | CA$1.00 | 22.0% +CA$4.5m | 110.5% | PE17.9x | |
| QPT Quest PharmaTech | CA$0.10 | 33.3% +CA$4.2m | -28.6% | PB0.2x |
